Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.50 |
| ▸ | OPRL1 | P41146 | 4/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.50 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.50 |
| ▸ | KCNA3 | P22001 | 4/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.40 |
| ▸ | HTR7 | P34969 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13876257 | 0.83 | OPRM1 (0.59) | ALOX5OPRM1OPRL1OPRK1OPRD1 | |
| SCHEMBL11796449 | 0.83 | ALOX5 (0.42) | MEN1KMT2ACYP2C9ALOX5OPRM1 | |
| SCHEMBL11799202 | 0.81 | DRD2 (0.41) | MEN1KMT2ACYP2C9ALOX5OPRM1 | |
| SCHEMBL6889536 | 0.81 | LIPG (0.42) | MEN1KMT2ACYP2C9ALOX5OPRM1 | |
| SCHEMBL11803104 | 0.81 | ALOX5 (0.53) | MEN1KMT2ACYP2C9ALOX5OPRM1 | |
| SCHEMBL11802151 | 0.80 | ALOX5 (0.52) | MEN1KMT2ACYP2C9ALOX5KCNA3 | |
| SCHEMBL10821867 | 0.79 | OPRM1 (0.56) | ALOX5OPRM1OPRL1OPRK1OPRD1 | |
| SCHEMBL14899046 | 0.79 | OPRM1 (0.56) | ALOX5OPRM1OPRL1OPRK1OPRD1 | |
| SCHEMBL11800670 | 0.79 | ALOX5 (0.42) | MEN1KMT2ACYP2C9ALOX5OPRM1 | |
| SCHEMBL11800757 | 0.79 | ALOX5 (0.48) | MEN1KMT2ACYP2C9ALOX5OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017116213-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL COMPOSITION CONTAINING SAME | 주식회사 동진쎄미켐 | 2017-07-06 | — | — | WO | disclosed |
| US-6884774-B2 | Cyclic hexapeptide derivatives | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2005-04-26 | — | — | US | disclosed |
| EP-1259535-B1 | CYCLIC HEXAPEPTIDE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO (JP) | 2005-04-13 | — | — | EP | disclosed |
| US-20030083238-A1 | Cyclic hexapeptide derivatives | ASTELLAS PHARMA INC. (JP) | 2003-05-01 | — | — | US | disclosed |
| EP-1259535-A1 | CYCLIC HEXAPEPTIDE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-11-27 | — | — | EP | disclosed |
| WO-2001060846-A1 | CYCLIC HEXAPEPTIDE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030083238-A1 | Cyclic hexapeptide derivatives | NGLY1, ALG1, CHIT1 | MEN1 1517/4885KMT2A 4695/4885CYP2C9 3770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.